Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001140361-22-025586
Filing Date
2022-07-08
Accepted
2022-07-08 15:51:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 PREC14A edge20002003x1_prec14a.htm PREC14A 1148071
2 edge20002003x1_pc01.jpg GRAPHIC 962945
3 edge20002003x1_pc02.jpg GRAPHIC 1035559
4 logo_dfkingast2x1.jpg GRAPHIC 30241
  Complete submission text file 0001140361-22-025586.txt   3943001
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filed by) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: PREC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 000-51173 | Film No.: 221074296
SIC: 2834 Pharmaceutical Preparations